Sabra Health Care REIT (SBRA) Reports Q2 Normalized FFO of 61c

Sabra Health Care REIT (NASDAQ: SBRA) reported Q2 EPS of $0.61, may not compare to the analyst estimate of $0.58. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $56.68 million.

GUIDANCE:

Sabra Health Care REIT sees FY2016 Normalized FFO of $2.33, versus the consensus of $2.23.

For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.

You May Also Be Interested In

• Barclays Starts Sabra Healthcare REIT Inc. (SBRA) at Equalweight
• DA Davidson Reiterates Neutral Rating on Fastenal (FAST), Says Would Buy on 'Any Meaningful Retrenchment'
• Redwood Trust reports record Aspire quarter, launches AI pricing tools